ProCE Banner Activity

Optimizing Outcomes for Relapsed/Refractory CLL/SLL and MCL

Slideset

Download this slideset featuring expert perspectives on the latest in BTK inhibitor therapy for patients with relapsed/refractory CLL and MCL.

Released: October 30, 2023

Expiration: October 29, 2024

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly